Cardiac Pacemaker Inc – A wholly owned subsidiary of Guidant Corporation – A wholly owned subsidiary of Boston Scientific Corporation

5 dispositifs dans la base de données

  • Modèle / numéro de série
    Model Number: viz FSN
  • Description du dispositif
    Active implantable medical devices
  • Modèle / numéro de série
    Model Number: 7740, 7741, 7742 Serial Number: All
  • Description du dispositif
    Active implantable medical devices
  • Modèle / numéro de série
    Model Number: VALITUDE™ CRT-P Models U125 and U128 ACCOLADE™ Pacemakers Models L300, L301, L310, L311, L321, L331 ESSENTIO™ Pacemakers Models L100, L101, L110, L111, L121, L131 VISIONIST™ CRT-P Models U225, U226, and U228 PROPONENT™ Pacemakers Models L200, L201, L209, L210, L211, L221, L231 ALTRUA™ 2 Pacemakers Models S701, S702, S722
  • Description du dispositif
    Active implantable medical devices
  • Modèle / numéro de série
    Model Number: EMBLEM S-ICD (A209, A219), SQ-RX (1010)
  • Description du dispositif
    Active implantable medical devices
  • Modèle / numéro de série
  • Description du dispositif
    Active implantable medical devices

2 fabricants avec un nom similaire

En savoir plus sur les données ici

  • Société-mère du fabricant (2017)
  • Commentaire du fabricant
    “We take a patient-first approach to assessing the applicability of every recall and communicate to regulatory bodies in all geographies where the recalled device is sold,” Boston Scientific said in a statement to ICIJ. “We have coordinated several recalls across many countries in a timely manner,” the company said, adding that it complies with all national laws, which can often vary and require different processes for reporting information or taking action on recalls. The company said it uses a rigorous and uniform process to take action on recalls and that “when we initiate a field action (e.g. recall, safety alert), every customer who has received an affected product receives a communication that includes a letter for the physician.” Note published by the authorities from the Netherlands: This message is a warning from the manufacturer. After placing a medical device on the market, the manufacturer is obliged to follow the device and, where necessary, to improve it. When there is a risk for the user, the manufacturer must take action. The manufacturer informs users and the inspection of this action with a warning (Field Safety Notice). See also medical device warnings. This is part of the supervision of medical technology.
  • Source
    IGJ
  • Société-mère du fabricant (2017)
  • Commentaire du fabricant
    “We take a patient-first approach to assessing the applicability of every recall and communicate to regulatory bodies in all geographies where the recalled device is sold,” Boston Scientific said in a statement to ICIJ. “We have coordinated several recalls across many countries in a timely manner,” the company said, adding that it complies with all national laws, which can often vary and require different processes for reporting information or taking action on recalls. The company said it uses a rigorous and uniform process to take action on recalls and that “when we initiate a field action (e.g. recall, safety alert), every customer who has received an affected product receives a communication that includes a letter for the physician.”
  • Source
    HPRA